tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

CUE Stock Latest News

Cue Biopharma’s Nasdaq Compliance Struggle: Risks and Implications for Future Stability
Company AnnouncementsCue Biopharma’s Nasdaq Compliance Struggle: Risks and Implications for Future Stability
1M ago
CUE
Cue Biopharma Reports Increased Revenue Amid Ongoing Losses
PremiumCompany Announcements
Cue Biopharma Reports Increased Revenue Amid Ongoing Losses
1M ago
CUE
Cue Biopharma reports Q3 EPS (17c), consensus (19c)
PremiumThe Fly
Cue Biopharma reports Q3 EPS (17c), consensus (19c)
1M ago
CUE
Cue names Daniel Baker interim CDO, CSO Amish Suri to transition to advisor role
PremiumThe Fly
Cue names Daniel Baker interim CDO, CSO Amish Suri to transition to advisor role
1M ago
CUE
CUE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CUE Upcoming Earnings Report: What to Expect?
1M ago
CUE
Cue Biopharma presents ‘positive’ update from Phase 1 trials of CUE-101, CUE-102
PremiumThe FlyCue Biopharma presents ‘positive’ update from Phase 1 trials of CUE-101, CUE-102
1M ago
CUE
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
CUE
ALLK
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
CUE
APVO
Cue Biopharma announces pricing of $12M public offering
PremiumThe Fly
Cue Biopharma announces pricing of $12M public offering
3M ago
CUE
Cue Biopharma announces common stock, warrant offering, no amount given
PremiumThe Fly
Cue Biopharma announces common stock, warrant offering, no amount given
3M ago
CUE
Cue Biopharma appoints Lucinda Warren as CBO
PremiumThe Fly
Cue Biopharma appoints Lucinda Warren as CBO
3M ago
CUE
JNJ
Cue Biopharma to present on CUE-401, CUE-100 series at conference
PremiumThe Fly
Cue Biopharma to present on CUE-401, CUE-100 series at conference
4M ago
CUE
Cue Biopharma price target lowered to $4 from $8 at Stifel
PremiumThe FlyCue Biopharma price target lowered to $4 from $8 at Stifel
4M ago
CUE
Cue Biopharma reports Q2 EPS (20c), consensus (25c)
Premium
The Fly
Cue Biopharma reports Q2 EPS (20c), consensus (25c)
4M ago
CUE
Options Volatility and Implied Earnings Moves Today, August 19, 2024
Premium
Market News
Options Volatility and Implied Earnings Moves Today, August 19, 2024
4M ago
EL
FN
Cue Biopharma price target lowered to $3 from $8 at Piper Sandler
PremiumThe Fly
Cue Biopharma price target lowered to $3 from $8 at Piper Sandler
5M ago
CUE
Cue Biopharma price target lowered to $2 from $15 at JMP Securities
PremiumThe Fly
Cue Biopharma price target lowered to $2 from $15 at JMP Securities
5M ago
CUE
Cue Biopharma Refocuses on Autoimmune Programs, Restructures Operations
PremiumCompany Announcements
Cue Biopharma Refocuses on Autoimmune Programs, Restructures Operations
5M ago
8K
CUE
Cue Biopharma announces strategic prioritization resulting in 25% workforce cut
PremiumThe Fly
Cue Biopharma announces strategic prioritization resulting in 25% workforce cut
5M ago
CUE
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe FlyJMP Securities healthcare analysts hold an analyst/industry conference call
6M ago
CUE
INO
Cue Biopharma Welcomes Michael J. Fox to Board, Shareholders Vote
Premium
Company Announcements
Cue Biopharma Welcomes Michael J. Fox to Board, Shareholders Vote
7M ago
8K
CUE
Cue Biopharma presents updated data from Phase 1 trial of CUE-101
Premium
The Fly
Cue Biopharma presents updated data from Phase 1 trial of CUE-101
7M ago
CUE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >